Collaboration spans the discovery, development and commercialization of cancer vaccines and other cancer immunotherapies in gastric, lung and prostate cancer
...
Read more
On 1 November 2013, Genentech announced that the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab) to be used with chlorambucil chemotherapy for the treatment of chronic lymphocytic leukemia (CLL). ...
Read more